The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes (IGLOOS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02694575 |
Recruitment Status :
Completed
First Posted : February 29, 2016
Last Update Posted : January 30, 2020
|
Sponsor:
University of Leicester
Collaborator:
University Hospitals, Leicester
Information provided by (Responsible Party):
University of Leicester
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 12, 2017 |
Actual Study Completion Date : | August 31, 2018 |
Publications:
IDF. IDF diabetes atlas 5th Edition. 2011.
DUK. Diabetes in the UK 2010 Key Satistics on Daibetes. 2010: 1-21.